Low-Dose Naltrexone for Chronic Pain: Off-Label Use

Summary

Low-dose naltrexone operates off-label between 1 mg and 4.5 mg by temporarily blocking opioid receptors, which may trigger endorphin release while influencing immune and inflammatory pathways. In this post, Dr. Jason W. Siefferman explains that the medication helps quiet central sensitization and nervous system reactivity rather than treating structural damage. Careful slow titration remains necessary, as higher doses can reduce efficacy and cause side effects such as sleep disruption or nausea. Ultimately, the article frames low-dose naltrexone as a long-term modulating medication within a diagnosis-first plan rather than a standalone cure.

Conditions and treatments discussed

• Low-Dose Naltrexone. Low-dose naltrexone temporarily blocks opioid receptors to influence endorphin production and immune pathways in complex chronic pain.
• Central Sensitization. Central sensitization involves amplified nervous system pain signaling and ongoing inflammatory reactivity.
• Medication Titration. Slow dose adjustments help prevent side effects like sleep disturbances and ensure optimal response over time.

What this shows about Manhattan Pain Medicine

Manhattan Pain Medicine integrates low-dose naltrexone as one component of a broad diagnostic strategy rather than relying on it as a single solution. In this article, Dr. Siefferman explains that modulating therapies cannot replace a proper mechanical workup, as dampening inflammatory signaling does not repair structural issues like disc herniations. The practice reports evaluating whether pain stems from mechanical factors, immune activation, or nervous system sensitization before prescribing targeted options. This diagnosis-first approach aligns with the model reported by Manhattan Pain Medicine, emphasizing clear driver identification over routine symptom suppression.